Congestive heart failure secondary to idiopathic hypoparathyroidism.
D000293:Adolescent; D002118:Calcium / Q000097:blood / Q000627:therapeutic use; D003951:Diagnostic Errors; D004077:Digoxin / Q000627:therapeutic use; D004562:Electrocardiography; D004569:Electroencephalography; D004830:Epilepsy, Tonic-Clonic / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D005942:Gluconates / Q000627:therapeutic use; D006321:Heart / Q000000981:diagnostic imaging; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006996:Hypocalcemia / Q000188:drug therapy; D007011:Hypoparathyroidism / Q000150:complications* / Q000175:diagnosis; D010102:Oxygen Inhalation Therapy; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D010758:Phosphorus / Q000097:blood; D011859:Radiography; D014807:Vitamin D / Q000627:therapeutic use
D005942:Gluconates; D014807:Vitamin D; D010758:Phosphorus; D010672:Phenytoin; D004077:Digoxin; D005665:Furosemide; D002118:Calcium; D010634:Phenobarbital